Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
HEAL-COVID will enrol patients when they are discharged from hospital, following their first admission for COVID-19. They will be randomised and given one of two drugs – apixaban and atorvastatin – and their progress tracked.
Lead Product(s): Apixaban
Therapeutic Area: Infections and Infectious Diseases Product Name: Elquis
Highest Development Status: Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 25, 2021